PFS
ABOS icon

Prospera Financial Services’s Acumen Pharmaceuticals ABOS Stock Holding History

Prospera Financial Services’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$134K Hold
50,000
– – ﹤0.01% 1425
2026
Q1 		$118K Hold
50,000
– – ﹤0.01% 1381
2025
Q4 		$106K Buy
+50,000
New +$99.2K ﹤0.01% 1331

Other funds holding ABOS

PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CA
Clune & Associates Chicago, Illinois $661M AUM 21.51% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
TFM
TFC Financial Management Boston, Massachusetts $902M AUM 21.74% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Prospera Financial Services's ABOS Position: Q2 2026 in Review

Prospera Financial Services held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 50,000 shares worth $134K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

Prospera Financial Services first reported a position in ABOS in Q4 2025 and has held it in 3 quarters since. 10 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Prospera Financial Services held 50,000 shares of Acumen Pharmaceuticals worth $134K as of Q2 2026.
  • Prospera Financial Services left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1425 holding.
  • Prospera Financial Services first reported a position in Acumen Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 10 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.